Evaluation of an Enzymatic Hemoglobin A1C Assay
DOI:
https://doi.org/10.21649/akemu.v30i2.5567Keywords:
Glycated hemoglobin, Alinity C, HPLC, method validationAbstract
Background: Different modalities have been designed for estimation of HbA1c, that include ion-exchange High Performance Liquid Chromatography (HPLC), immunoassay, enzymatic assays and capillary electrophoresis. Although based on different principles, these analytical processes have to exhibit robust performance so that an overall comparability of assay values can be ensured which are traceable to the available reference method.
Objectives: Objective of the study was to evaluate HbA1c measurement on Abbott Alinity C system against ion exchange high performance liquid chromatography.
Methods: We performed different experiments to evaluate measurement of HbA1c on Alinity C system by Abbott. These studies included accuracy, precision, linearity, carry over and method comparison in patients without any hemoglobin variants. Evaluation Protocol (EP) evaluator was used for data analysis.
Results: All the experiments passed the minimum passing criteria. All the claims by the vendor were successfully verified with and addition that vendor claims 12-hour stability while our study showed a stability of 18 hours. In precision the coefficient of variance in our experiment showed better results.
Conclusion: Alinity C system can be used reliably and efficiently for the assessment of HbA1c in patients without haemoglobin variants as our study did not include samples with variant hemoglobin.
References
Teodoro-Morrison T, Janssen MJ, Mols J, Hendrickx BH, Velmans MH, Lotz J, et al. Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system. Clin Chem Lab Med. 2015;53(1):125-32. doi: 10.1515/cclm-2014-0310. PubMed PMID: 25153395.
Butt N, Bano F, Ghani M, Ahmed AM, Majeed N. Association of serum advanced glycation (AGEs) end products, apolipoprotein-B and zinc in severity of T2DM retinopathy.PJPS. 2021;34(2):803-8.
Majeed N, Ahmad TM, Hayat A, Israr S, Saddique A, Shabbir S. Role of Serum Lipid and Apolipoprotein Ratios in Prediction of Diabetic Retinopathy. Biosight. 2023;4(1):3-10. doi: https://doi.org/10.46568/bios.v4i1.85.
Lenters-Westra E, English. Evaluating new HbA1c methods for adoption by the IFCC and NGSP reference networks using international quality targets.CCLM. 2017;55(9):1426-34.
Gillery P. HbA1c and biomarkers of diabetes mellitus in Clinical Chemistry and Laboratory Medicine: ten years after. CCLM. 2023;61(5):861-72.
Rohlfing C, Hanson S, Weykamp C, Siebelder C, Higgins T, Molinaro R, et al. Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods. 2016;455(1):80-3.
Association AD. Addendum. 2 Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes care. 2021;44(Supplement_1):S15-S33.
Jaisson S, Desmons A, Renard B, Chevelle B, Leroy N, Gillery PJCCA. Analytical performances of a new enzymatic assay for hemoglobin A1c. 2014;434(1):48-52.
Berman M, Templin L, editors. Performance of the Enzymatic Alinity c Hemoglobin A1c Assay. 71st AACC Annual Scientific Meeting Abstracts; 2019: AACC.
Chakraborty S, Chakraborty S, Ghosh A, Chakraborty SS. A Comparative Evaluation of Estimation of Glycated Haemoglobin by Immunoturbidimetry and High Performance Liquid Chromatography in a Tertiary Care Hospital of Kolkata. IJRR. 2019;6(3):155-158.
Weykamp C, John G, Gillery P, English E, Ji L, Lenters-Westra E, et al. Investigation of 2 models to set and evaluate quality targets for HbA1c: biological variation and sigma-metrics. Clinical chemistry. 2015;61(5):752-9.
Stokes C, Frost S, Frost L, Mcinerney N, O’Dwyer S. A-070 A fully automated HbA1c Assay on the DxC 500 AU Clinical Chemistry Analyser. Clinical Chemistry. 2023;69(Supplement_1):hvad097. 67.
Clinical LSI. EP09‐A3: Measurement Procedure Comparison and Bias Estimation Using Patient Samples. 2013.
Petrides AK, Dahlin JL, Melanson SE. Method validation. Contemporary Practice in Clinical Chemistry: Elsevier; 2020. p. 57-75.
Cihan M, Abdullah Ü, KILINÇKAYA MF, Noyan T. Comparison of high performance liquid chromatography and turbidimetric inhibition immunoassay methods for measurement of hemoglobin A1c. JHSM. 2022;5(5):1281-5.
Lee JH, Kim S, Jun S-H, Seo JD, Nam Y, Song SH, et al. Analytical performance evaluation of the Norudia HbA1c assay. J. Clin. Lab. Anal . 2020;34(11):e23504. doi: https://doi.org/10.1002/jcla.23504.
Núñez-Jurado D, Montenegro-Martínez J, Rubio-Sánchez R, Conde-Sánchez M, Domínguez-Pascual I. Evaluation of the Premier Hb9210 instrument for HbA1c determination. Scandinavian. J. Clin. Lab .2023;83(8):569-75.
Ohde S, Deshpande GA, Yokomichi H, Takahashi O, Fukui T, Yamagata Z. HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study. Diabetes research clinical practice. 2018;135(1):166-71.
Pasqualetti S, Carnevale A, Dolci A, Panteghini M. A step towards optimal efficiency of HbA1c measurement as a first-line laboratory test: the TOP-HOLE (Towards OPtimal glycoHemOgLobin tEsting) project. CCLM. 2022;60(3):441-50.
Braga F, Panteghini M. Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. Clinica Chimica Acta. 2014;432(1):55-61.
Chaila MZ, Viniegra M, Gagliardino JJ, Martínez A, Simesen de Bielke MG, Frusti M, et al. Glycated Hemoglobin Measurement: Comparison of Three Methods Versus High Performance Liquid Chromatography. JDST . 2022;16(3):724-31. doi: 10.1177/1932296821997179. PubMed PMID: 33686874.
Luis Monaco B, Pablo Salgado B, Carlos Buso M, Claudio Daniel Gonzalez M. Glycated Hemoglobin Measurement: Comparison of Three Methods Versus High Performance Liquid Chromatography. JDST . 2021;77(1):1-8.
Sriwimol W, Choosongsang P, Choosongsang P, Treerut P, Muenniam B, Makkong P, Pocathikorn A. Strong correlation and high comparability of capillary electrophoresis and three different methods for HbA1c measurement in a population without hemoglobinopathy. Scandinavian . J. Clin. Lab . 2020;80(2):139-50. doi: 10.1080/00365513.2019.1703213.
Mukherjee B, Hooda C, Singh V, Sahu R, Singh MU. Comparison of NGSP Certified Methods and their Cost Analysis for Estimation of HbA1c-A Cross-sectional Study. JCDR . 2023;17(2):BC01-BC4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk